A COVID-19 screening tool for oncology telephone triage.
COVID-19
/ diagnosis
COVID-19 Testing
/ methods
Checklist
Emergencies
/ classification
Health Knowledge, Attitudes, Practice
Humans
Implementation Science
Infection Control
/ methods
Medical Oncology
/ education
Neoplasms
/ nursing
Nurse Clinicians
/ education
Oncology Nursing
/ education
Pandemics
Quarantine
SARS-CoV-2
San Francisco
/ epidemiology
Surveys and Questionnaires
Telephone
Triage
/ methods
COVID-19
Cancer
Screening
Symptoms
Telephone triage
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
19
06
2020
accepted:
20
08
2020
pubmed:
29
8
2020
medline:
25
2
2021
entrez:
29
8
2020
Statut:
ppublish
Résumé
Symptoms associated with COVID-19 infection have made the assessment and triage of cancer patients extremely complicated. The purpose of this paper is to describe the development and implementation of a COVID-19 screening tool for oncology telephone triage. An Ambulatory Oncology Clinical Nurse Educator and three faculty members worked on the development of an oncology specific triage tool based on the challenges that oncology nurses were having with the generic COVID triage tool. A thorough search of the published literature, as well as pertinent websites, verified that no screening tool for oncology patients was available. The screening tool met a number of essential criteria: (1) simple and easy to use, (2) included the most common signs and symptoms as knowledge of COVID-19 infection changed, (3) was congruent with the overall screening procedures of the medical center, (4) included questions about risk factors for and environmental exposures related to COVID-19, and (5) assessed patient's current cancer history and treatment status. Over a period of 3 weeks, the content and specific questions on the tool were modified based on information obtained from a variety of sources and feedback from the triage nurses. Within 1 month, the tool was developed and implemented in clinical practice. Oncology clinicians can modify this tool to triage patients as well as to screen patients in a variety of outpatient settings (e.g., chemotherapy infusion units, radiation therapy departments). The tool will require updates and modifications based on available resources and individual health care organizations' policies and procedures.
Identifiants
pubmed: 32856214
doi: 10.1007/s00520-020-05713-5
pii: 10.1007/s00520-020-05713-5
pmc: PMC7453077
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2057-2062Commentaires et corrections
Type : CommentIn
Références
Hen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/s0140-6736(20)30211-7
doi: 10.1016/s0140-6736(20)30211-7
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337. https://doi.org/10.1016/s1470-2045(20)30096-6
doi: 10.1016/s1470-2045(20)30096-6
pubmed: 32066541
pmcid: 7159000
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10(6):783–791. https://doi.org/10.1158/2159-8290.Cd-20-0422
doi: 10.1158/2159-8290.Cd-20-0422
pubmed: 7309152
pmcid: 7309152
Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C (2020) Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol 31:1088. https://doi.org/10.1016/j.annonc.2020.04.006
doi: 10.1016/j.annonc.2020.04.006
pubmed: 7172785
pmcid: 7172785
Moon S (2020) The CDC has changed the criteria for testing patients with corona virus after the first case of unknown origin was confirmed. CNN. https://www.cnn.com/2020/02/27/health/us-cases-coronavirus-community-transmission/index.html .
Hickey M, Newton S (2019) Telephone triage for oncology nurses, 3rd edn. Oncology Nursing Society, Pittsburgh
Judson TJ, Odisho AY, Neinstein AB, Chao J, Williams A, Miller C, Moriarty T, Gleason N, Intinarelli G, Gonzales R (2020) Rapid design and implementation of an integrated patient self-triage and self-scheduling tool for COVID-19. J Am Med Inform Assoc. 27:860. https://doi.org/10.1093/jamia/ocaa051
doi: 10.1093/jamia/ocaa051
pubmed: 32267928
Centers for Disease Control and Prevention (2020) Corona disease 2019 (COVID-19): symptoms & testing 2020. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/index.html .
Allday E, Ho C (2020) Bay Area officials scramble to contain corona virus as UCSF accepts two patients. San Francisco Chronicle, https://www.sfchronicle.com/bayarea/article/U-S-officials-take-aggressive-measures-to-15027383.php
Allday E (2020) Bay Area orders “shelter in place,” only essential businesses open in 6 counties. 2020, https://www.sfchronicle.com/local-politics/article/Bay-Area-must-shelter-in-place-Only-15135014.php
Centers for Disease Control and Prevention (2020) Evaluating and testing persons for coronavirus disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/hpc/clinical-criteria.html .
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032
doi: 10.1056/NEJMoa2002032
pubmed: 32109013
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, McCreery B, Jagels B, Crane A, Byrd DR, Pergam SA, Davidson NE, Liu C, Stewart FM (2020) Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw:1-4. doi: https://doi.org/10.6004/jnccn.2020.7560
Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X (2020) Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol. doi: https://doi.org/10.1002/jmv.25972
Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C (2020) A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an International Collaborative Group. Oncologist. 25:e936. https://doi.org/10.1634/theoncologist.2020-0213
doi: 10.1634/theoncologist.2020-0213
pubmed: 32243668
pmcid: 7288661
Papachristou N, Barnaghi P, Cooper B, Kober KM, Maguire R, Paul SM, Hammer M, Wright F, Armes J, Furlong EP, McCann L, Conley YP, Patiraki E, Katsaragakis S, Levine JD, Miaskowski C (2019) Network analysis of the multidimensional symptom experience of oncology. Sci Rep 9(1):2258. https://doi.org/10.1038/s41598-018-36973-1
doi: 10.1038/s41598-018-36973-1
pubmed: 30783135
pmcid: 6381090
Miaskowski C, Cooper BA, Aouizerat B, Melisko M, Chen LM, Dunn L, Hu X, Kober KM, Mastick J, Levine JD, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N (2017) The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. Eur J Cancer Care (Engl) 26(3). https://doi.org/10.1111/ecc.12437
Ritchie CS, Zhao F, Patel K, Manola J, Kvale EA, Snyder CF, Fisch MJ (2017) Association between patients’ perception of the comorbidity burden and symptoms in outpatients with common solid tumors. Cancer 123(19):3835–3842. https://doi.org/10.1002/cncr.30801
doi: 10.1002/cncr.30801
pubmed: 28608952
pmcid: 5610613
Renzi C, Kaushal A, Emery J, Hamilton W, Neal RD, Rachet B, Rubin G, Singh H, Walter FM, de Wit NJ, Lyratzopoulos G (2019) Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Rev Clin Oncol 16(12):746–761. https://doi.org/10.1038/s41571-019-0249-6
doi: 10.1038/s41571-019-0249-6
pubmed: 31350467